ClinConnect ClinConnect Logo
Search / Trial NCT00962468

European Quality of Care Pathways Study on Chronic Obstructive Pulmonary Disease (COPD)

Launched by EUROPEAN PATHWAY ASSOCIATION · Aug 19, 2009

Trial Information

Current as of May 27, 2025

Completed

Keywords

Pulmonary Disease, Chronic Obstructive Critical Pathway Cluster Randomized Controlled Trial Safety Efficiency

ClinConnect Summary

Healthcare is changing towards more patient focused care. The organization of the care process related to quality, efficiency and accessibility is one of the main areas of interest within the next years for clinicians, healthcare managers and policy makers. A main method to (re)organize a care process is the development and implementation of a care pathway. Care pathways, also known as clinical pathways or critical pathways, are used worldwide for a variety of patient groups. The European Pathway Association (E-P-A) defines a care pathway as: "A complex intervention for the mutual decision ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inclusion criteria on cluster level are:
  • 1. Written agreement to participate in the study;
  • 2. Agreement that a care pathway for COPD will not be developed and used within the time frame of the study when randomized in the control group.
  • Inclusion criteria on patient level are:
  • 1. Written informed consent;
  • 2. All consecutive admissions with COPD exacerbation;
  • 3. Hospitalization for at least 48 hours;
  • 4. Moderate, severe or very severe COPD;
  • 5. Each patient will be included only once in the study at initial hospitalization, even if the patient had been hospitalized more than once.
  • Exclusion Criteria:
  • Exclusion criteria on patient level:
  • 1. Admission required to intensive care unit;
  • 2. Need for Invasive Positive Pressure Ventilation (IPVV).
  • Inclusion criteria on multidisciplinary team level:
  • 1. Team members are involved in direct patient care responsibilities for COPD;
  • 2. Minimum representation of the core disciplines according to COPD literature;

About European Pathway Association

The European Pathway Association (EPA) is a leading organization dedicated to advancing the field of clinical pathways in healthcare. Committed to enhancing patient care through evidence-based practices, the EPA fosters collaboration among healthcare professionals, researchers, and policymakers across Europe. By promoting the development and implementation of clinical pathways, the association aims to improve health outcomes, optimize resource utilization, and streamline healthcare processes. Through innovative research and educational initiatives, the EPA plays a pivotal role in shaping the future of healthcare delivery, ensuring that best practices are translated into effective clinical solutions.

Locations

Patients applied

0 patients applied

Trial Officials

Kris Vanhaecht, PhD

Study Director

KU Leuven

Walter Sermeus, PhD

Principal Investigator

KU Leuven

Massimiliano Panella, PhD

Principal Investigator

Amedeo Avogadro University of Eastern Piemont

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials